tiprankstipranks
Trending News
More News >
Bioqual Inc (BIOQ)
OTHER OTC:BIOQ
US Market

Bioqual (BIOQ) Ratios

Compare
18 Followers

Bioqual Ratios

BIOQ's free cash flow for Q2 2025 was $0.09. For the 2025 fiscal year, BIOQ's free cash flow was decreased by $ and operating cash flow was $-0.02. See a summary of the company’s cash flow.
Ratios
TTM
Aug 24Aug 23May 23Aug 21
Liquidity Ratios
Current Ratio
4.41 3.72 4.02 3.61 3.25
Quick Ratio
4.41 3.72 4.02 3.61 3.25
Cash Ratio
1.78 2.12 2.03 0.88 0.22
Solvency Ratio
0.10 0.06 0.16 0.28 0.52
Operating Cash Flow Ratio
0.38 0.35 1.22 0.99 0.03
Short-Term Operating Cash Flow Coverage
0.66 0.74 2.61 2.39 0.10
Net Current Asset Value
$ -11.42M$ 10.34M$ 11.94M$ 6.24M$ 6.06M
Leverage Ratios
Debt-to-Assets Ratio
0.90 0.29 0.06 0.30 0.30
Debt-to-Equity Ratio
1.84 0.46 0.10 0.49 0.50
Debt-to-Capital Ratio
0.65 0.31 0.09 0.33 0.33
Long-Term Debt-to-Capital Ratio
0.47 0.00 0.00 0.29 0.29
Financial Leverage Ratio
2.03 1.58 1.50 1.63 1.68
Debt Service Coverage Ratio
1.08 0.19 0.85 1.94 4.38
Interest Coverage Ratio
0.00 0.00 0.00 0.00 0.00
Debt to Market Cap
1.03 0.10 0.06 0.27 0.30
Interest Debt Per Share
73.43 18.49 4.01 20.71 20.94
Net Debt to EBITDA
14.09 -2.58 -3.96 1.63 1.12
Profitability Margins
Gross Profit Margin
-0.73%-3.88%12.68%20.11%19.66%
EBIT Margin
1.38%-3.88%0.81%1.81%9.94%
EBITDA Margin
8.44%1.04%5.18%11.12%22.32%
Operating Profit Margin
0.27%-3.88%-0.03%1.76%9.88%
Pretax Profit Margin
1.69%-2.63%0.81%1.81%9.94%
Net Profit Margin
0.97%-2.14%0.83%1.33%7.95%
Continuous Operations Profit Margin
0.97%-2.14%0.83%1.33%7.95%
Net Income Per EBT
57.76%81.47%101.48%73.73%79.99%
EBT Per EBIT
622.48%67.86%-2426.15%102.75%100.68%
Return on Assets (ROA)
0.62%-1.84%0.85%1.36%8.30%
Return on Equity (ROE)
1.26%-2.90%1.28%2.22%13.96%
Return on Capital Employed (ROCE)
0.19%-3.89%-0.04%2.08%12.19%
Return on Invested Capital (ROIC)
0.10%-2.93%-0.04%1.44%9.22%
Return on Tangible Assets
0.63%-1.87%0.87%1.39%8.44%
Earnings Yield
1.35%-2.60%0.74%1.22%8.40%
Efficiency Ratios
Receivables Turnover
3.63 3.71 4.18 2.94 2.47
Payables Turnover
42.95 26.75 37.09 31.40 16.16
Inventory Turnover
0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
1.12 2.01 2.38 2.06 2.16
Asset Turnover
0.64 0.86 1.04 1.02 1.04
Working Capital Turnover Ratio
2.17 2.12 2.61 2.87 3.09
Cash Conversion Cycle
92.07 84.69 77.39 112.55 125.08
Days of Sales Outstanding
100.57 98.33 87.24 124.17 147.67
Days of Inventory Outstanding
0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
8.50 13.64 9.84 11.62 22.59
Operating Cycle
100.57 98.33 87.24 124.17 147.67
Cash Flow Ratios
Operating Cash Flow Per Share
2.46 3.29 10.45 9.16 0.35
Free Cash Flow Per Share
2.04 3.03 9.79 6.66 -5.11
CapEx Per Share
0.42 0.27 0.67 2.50 5.46
Free Cash Flow to Operating Cash Flow
0.83 0.92 0.94 0.73 -14.59
Dividend Paid and CapEx Coverage Ratio
2.68 4.29 8.96 2.62 0.05
Capital Expenditure Coverage Ratio
5.90 12.33 15.67 3.67 0.06
Operating Cash Flow Coverage Ratio
0.03 0.18 2.61 0.44 0.02
Operating Cash Flow to Sales Ratio
0.05 0.06 0.16 0.13 <0.01
Free Cash Flow Yield
5.45%6.72%13.50%8.77%-7.30%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
74.02 -38.40 134.26 81.72 11.90
Price-to-Sales (P/S) Ratio
0.72 0.82 1.11 1.09 0.95
Price-to-Book (P/B) Ratio
0.94 1.11 1.72 1.82 1.66
Price-to-Free Cash Flow (P/FCF) Ratio
18.36 14.87 7.41 11.40 -13.69
Price-to-Operating Cash Flow Ratio
15.24 13.67 6.94 8.30 199.80
Price-to-Earnings Growth (PEG) Ratio
0.43 0.12 -3.20 -0.97 -0.70
Price-to-Fair Value
0.94 1.11 1.72 1.82 1.66
Enterprise Value Multiple
22.63 76.40 17.45 11.43 5.36
Enterprise Value
88.89M 38.94M 52.90M 79.61M 79.15M
EV to EBITDA
22.63 76.40 17.45 11.43 5.36
EV to Sales
1.91 0.80 0.90 1.27 1.20
EV to Free Cash Flow
48.64 14.39 6.04 13.30 -17.31
EV to Operating Cash Flow
40.39 13.22 5.65 9.67 252.58
Tangible Book Value Per Share
38.84 39.27 40.90 40.72 40.97
Shareholders’ Equity Per Share
39.99 40.42 42.05 41.87 42.12
Tax and Other Ratios
Effective Tax Rate
0.42 0.19 -0.01 0.26 0.20
Revenue Per Share
52.03 54.64 65.44 69.75 73.96
Net Income Per Share
0.51 -1.17 0.54 0.93 5.88
Tax Burden
0.58 0.81 1.01 0.74 0.80
Interest Burden
1.23 0.68 1.00 1.00 1.00
Research & Development to Revenue
0.00 0.00 0.00 0.01 0.02
SG&A to Revenue
0.14 0.00 0.00 0.12 0.10
Stock-Based Compensation to Revenue
0.00 0.00 0.00 0.00 0.00
Income Quality
-4.31 -2.81 19.36 9.85 0.06
Currency in USD